Increasing peptide sequence coverage by tandem mass spectrometry improves confidence
in database search-based peptide identification and facilitates mapping of post-translational …

Diseases at the molecular level are complex and patient dependent, necessitating development
of strategies that enable precision treatment to optimize clinical outcomes. Organoid …

Mass spectrometry (MS)-based proteomics workflows can crudely be classified into two distinct
regimes, targeting either relatively small peptides (ie, 0.7 kDa < M w < 3.0 kDa) or small …

Here, we recorded serum proteome profiles of 33 severe COVID-19 patients admitted to
respiratory and intensive care units because of respiratory failure. We received, for most patients…

Quantitative and qualitative protein characteristics are regulated at genomic, transcriptomic,
and posttranscriptional levels. Here, we integrated in-depth transcriptome and proteome …

The original PRIDE Converter tool greatly simplified the process of submitting mass
spectrometry (MS)-based proteomics data to the PRIDE database. However, after much user …

Although mass-spectrometry-based screens enable thousands of protein phosphorylation
sites to be monitored simultaneously, they often do not cover important regulatory sites. Here, …

Tumor heterogeneity is a major cause of therapeutic resistance. Immunotherapy may exploit
alternative vulnerabilities of drug-resistant cells, where tumor-specific human leukocyte …

Ion mobility separates molecules in the gas-phase based on their physico-chemical properties,
providing information about their size as collisional cross-sections. The timsTOF Pro …

Human milk is a vital biofluid containing a myriad of molecular components to ensure an
infant’s best start at a healthy life. One key component of human milk is β-casein, a protein …